Taming regulatory T cells by autologous T cell immunization: A potential new strategy for cancer immune therapy

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 593-595

  Zhang, Yan ^a   Wang, Li ^a   Li, Dangsheng ^b   Li, Ningli ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

Anti tumor immunity; Autologous T cell; Immune therapy; Immunization; Regulatory T cells; Tregs

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGENIC AGENT; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ARTICLE; AUTOLOGOUS T CELL IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; EFFECTOR CELL; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ADOPTIVE IMMUNOTHERAPY; ANIMAL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; ISOGRAFT; LYMPHOCYTE ACTIVATION; LYMPHOMA, T-CELL; METABOLISM; MOUSE; PATHOLOGY; TUMOR ESCAPE;

ANIMALS; ANTIGENS, CD4; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY, HUMORAL; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOMA, T-CELL; MICE; MITOGENS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, ISOGENEIC; TUMOR ESCAPE;

EID: 63649123678     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.026     Document Type: Article

References (26)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
2. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057
3. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
4. Maloy K.J., and Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2 (2001) 816-822
5. Zou W. Regulatory T cells, tumor immunity and immunotherapy. Nat Rev Immunol 6 (2006) 295-307
6. Bursuker I., and North R.J. Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity. J Exp Med 159 (1984) 1312-1321
7. North R.J., and Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma.I. Ly-1 + 2-suppressor T cells downregulate the generation of Ly-1-2+ effector T cells. J Exp Med 159 (1984) 1295-1311
8. North R.J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 155 (1982) 1063-1074
9. Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T., and Nakayama E. Tumour rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res 59 (1999) 3128-3133
10. Shimizu J., Yamazaki S., and Sakaguchi S. Induction of tumour immunity by removing CD25 + CD4 + T cells: a common basis between tumour immunity and autoimmunity. J Immunol 163 (1999) 5211-5218
11. Sutmuller R.P., van Duivenvoorde L.M., van Elsas A., Schumacher T.N., Wildenberg M.E., Allison J.P., et al. Synergism of cytotoxic T lymphocyte associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194 (2001) 823-832
12. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., et al. CD4 + T-cell subset inhibits antigenspecific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
13. Weiner H.L. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev 182 (2001) 207-214
14. Cosmi L., Liotta F., Lazzeri E., Francalanci M., Angeli R., Mazzinghi B., et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102 (2003) 4107-4114
15. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
16. Lider O., Beraud E., Reshef T., Friedman A., and Cohen I.R. Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector T cells. (2). Induction of a protective anti-idiotypic response. J Autoimmun 2 (1989) 87-99
17. Ben-Nun A., Wekerle H., and Cohen I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292 (1981) 60-61
18. Vandevyver C., Mertens N., Van den Elsen P., Medaer R., Raus J., and Zhang J. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 25 (1995) 958-968
19. Hong J., Zang Y.C.Q., Tejada-Simon M., Kozovska M., Li S., Singh R., et al. A common TCR V-D-J sequence in Vβ13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol 163 (1999) 3530-3538
20. Zang Y., Hong J., Killian J., Rivera V.M., and Zhang J.Z. Preferential recognition of hypervariable region sequence by anti-idiotypic T cells induced by T cell vaccination in patients with multiple sclerosis. J Immunol 164 (2000) 4011-4017
21. Hong J., Zang Y.C., Tejada-Simon M.V., Li S., Rivera V.M., Killian J., et al. Reactivity and regulatory properties of anti-idiotypic antibodies induced by T cell vaccination in patients with multiple sclerosis. J Immunol 165 (2000) 6858-6864
22. Hong J., Li N., Zhang X., Zheng B., and Zhang J.Z. Induction of CD4-CD25- regulatory T cells by copolymer-I through activation of transcription factor Foxp3. PNAS 102 (2005) 6449-6454
23. Chen G.J., Li N.L., Zang Y.Q., Zhang D.Q., He D.Y., Feng G.Z., et al. Vaccination with selected synovial T cells in Rheumatoid arthritis. Arthritis Rheum 56 (2007) 453-463
24. Wang L., Du F., Cao Q., Sheng H., Shen B., Zhang Y., et al. Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45β. Cell Res 16 (2006) 702-712
25. Cao Q., Wang L., Du F., Shen H., Shen B., Zhang Y., et al. Down-regulation of CD4+CD25+ regulatory T cells may underlie enhanced anti-tumor immunity caused by immunization with activated autologous T cells. Cell Res 17 (2007) 627-637
26. Young K.J., DuTemple B., Phillips M.J., and Zhang L. Inhibition of graft-versus-host disease by double-negative regulatory T cells. J Immunol 171 (2003) 134-141